期刊
CLINICAL EPIGENETICS
卷 13, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s13148-021-01175-6
关键词
DNA methylation; Incident coronary heart disease; Epigenome-wide association study
资金
- JPI ERA-HDHL DIMENSION project
- UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/S020845/1, BB/T019980/1]
Coronary heart disease (CHD) is a major global cause of mortality. Recent studies have identified DNA methylation signatures associated with CHD development, suggesting their potential use in predicting future CHD events. New mechanisms involved in CHD progression have been uncovered through DNA methylation studies.
Coronary heart disease (CHD) is a type of cardiovascular disease (CVD) that affects the coronary arteries, which provide oxygenated blood to the heart. It is a major cause of mortality worldwide. Various prediction methods have been developed to assess the likelihood of developing CHD, including those based on clinical features and genetic variation. Recent epigenome-wide studies have identified DNA methylation signatures associated with the development of CHD, indicating that DNA methylation may play a role in predicting future CHD. This narrative review summarises recent findings from DNA methylation studies of incident CHD (iCHD) events from epigenome-wide association studies (EWASs). The results suggest that DNA methylation signatures may identify new mechanisms involved in CHD progression and could prove a useful adjunct for the prediction of future CHD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据